Jubilant Cadista Pharmaceuticals, Inc.

8 FDA enforcement actions

8 Total Recalls

1 Class I

3 Class II

4 Class III

Firm Details

Product Types: drug
States: MD

All Recalls

Class III: Low Risk 12/27/2022 drug

Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.
Class II: Risk 07/18/2022 drug

Failed Dissolution Specifications
Class II: Risk 07/18/2022 drug

Failed dissolution specifications.
Class III: Low Risk 04/01/2022 drug

Subpotent
Class I: Dangerous 03/08/2022 drug

Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Class III: Low Risk 08/20/2021 drug

Subpotent
Class II: Risk 04/01/2021 drug

Failed Dissolution Specifications
Class III: Low Risk 02/19/2021 drug

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.